SCHEMBL30764758

SCHEMBL30764758

O=C(Cc1ccc(Cl)cc1)N1CC2(CN(Cc3ccccn3)C2)C1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.59
ALDH1A1 P00352 3/20 0.59
HSD11B1 P28845 1/20 0.48
GHSR Q92847 2/20 0.46
TACR3 P29371 1/20 0.45
NPC1 O15118 1/20 0.45
RAB9A P51151 1/20 0.45
GFER P55789 1/20 0.44
ATM Q13315 1/20 0.44
FNTA P49354 1/20 0.44
FNTB P49356 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.43
CHRM2 P08172 1/20 0.43
KMT2A Q03164 2/20 0.43
MEN1 O00255 1/20 0.42
GPR183 P32249 1/20 0.42
CNR1 P21554 1/20 0.42
L3MBTL1 Q9Y468 2/20 0.41
NPSR1 Q6W5P4 2/20 0.41
HPGD P15428 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30764707 0.84 HSD11B1 (0.55) KDM4EALDH1A1HSD11B1GFERATM
SCHEMBL30764717 0.82 HSD11B1 (0.46) KDM4EALDH1A1HSD11B1GHSRGFER
SCHEMBL30764713 0.81 HSD11B1 (0.47) KDM4EALDH1A1HSD11B1GHSRNPC1
SCHEMBL30764715 0.80 HSD11B1 (0.51) HSD11B1GHSRGFERATMCHRM2
SCHEMBL30764763 0.78 HSD11B1 (0.46) HSD11B1GHSRSMN1; SMN2CHRM2KMT2A
SCHEMBL30764702 0.75 GHSR (0.46) ALDH1A1HSD11B1GHSRCHRM2KMT2A
SCHEMBL30764735 0.75 HSD11B1 (0.51) ALDH1A1HSD11B1GFERATMKMT2A
SCHEMBL30764749 0.74 HSD11B1 (0.49) HSD11B1GFERATMKMT2AMEN1
SCHEMBL30764755 0.74 GAA (0.54) KDM4EALDH1A1HSD11B1NPC1RAB9A
SCHEMBL30764757 0.73 HSD11B1 (0.46) ALDH1A1HSD11B1GHSRGFERATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4568968-A1 (AZA)SPIROHEPTANE DERIVATIVES FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS Remynd N.V. (BE) 2025-06-18 EP disclosed
WO-2024033479-A1 (AZA)SPIROHEPTANE DERIVATIVES FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS REMYND N.V. (BE) 2024-02-15 WO disclosed